| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1999) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 21K6M2I7AG |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Interferon gamma receptor agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteopetrosis | 4 | D010022 | ClinicalTrials |
| Osteopetrosis | 4 | D010022 | ClinicalTrials |
| Pneumonia, Ventilator-Associated | 3 | D053717 | ClinicalTrials |
| Condylomata Acuminata | 3 | D003218 | ClinicalTrials |
| Melanoma | 3 | D008545 | ClinicalTrials |
| Pulmonary Fibrosis | 3 | D011658 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Candidemia | 3 | D058387 | ClinicalTrials |
| Melanoma | 3 | D008545 | ClinicalTrials |
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 3 | D054990 | ClinicalTrials |
| Liver Cirrhosis | 2 | D008103 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials |
| Bronchiolitis Obliterans | 2 | D001989 | ClinicalTrials |
| Meningitis, Cryptococcal | 2 | D016919 | ClinicalTrials |
| Mycobacterium avium-intracellulare Infection | 2 | D015270 | ClinicalTrials |
| Arthritis, Reactive | 2 | D016918 | ClinicalTrials |
| Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
| Leukocyte-Adhesion Deficiency Syndrome | 2 | D018370 | ClinicalTrials |
| Mycobacterium Infections | 2 | D009164 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Friedreich Ataxia | 2 | D005621 | ClinicalTrials |
| Aspergillosis | 2 | D001228 | ClinicalTrials |
| Lung Diseases | 2 | D008171 | ClinicalTrials |
| Sezary Syndrome | 2 | D012751 | ClinicalTrials |
| Sarcoma, Ewing | 1 | D012512 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Xerostomia | 1 | D014987 | ClinicalTrials |
| Uveitis | 1 | D014605 | ClinicalTrials |
| Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
| Rhabdomyosarcoma | 1 | D012208 | ClinicalTrials |
| Osteosarcoma | 1 | D012516 | ClinicalTrials |
| Neuroblastoma | 1 | D009447 | ClinicalTrials |
| Psoriasis | 1 | D011565 | ClinicalTrials |
| Uveitis, Anterior | 1 | D014606 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial | 1 | D000077216 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Retinal Degeneration | 1 | D012162 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 98059-61-1 |
| ChEMBL | CHEMBL1201564 |
| FDA SRS | 21K6M2I7AG |
CONTENTS